Drug Approval | April 07, 2024
Eugia Steriles gets 3 observations from USFDA for injectable facility
The observations are procedural in nature and will be responded to within the stipulated time
The observations are procedural in nature and will be responded to within the stipulated time
WINREVAIR is a breakthrough biologic for this rare, progressive disease
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
The inspection classification was determined by the agency as Voluntary Action Indicated
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
Subscribe To Our Newsletter & Stay Updated
